ClinicalTrials.Veeva

Menu
B

Baptist Memorial Health Care | Baptist Clinical Research Institute

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Divarasib
Nivolumab
Etavopivat
Docetaxel
Palbociclib
Sitravatinib
INB03
Ribociclib
Sacituzumab
Elritercept

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 22 total trials

9-ING-41 in Patients with Advanced Cancers

GSK-3β is a potentially important therapeutic target in human malignancies. The Actuate 1801 Phase 1/2 study is designed to evaluate the safety and e...

Active, not recruiting
Neoplasm of Lung
Neoplasms Pancreatic
Drug: Gemcitabine - 21 day cycle
Drug: 9-ING-41

The purpose of this study is to assess the safety and efficacy of divarasib compared to locally approved KRAS G12C inhibitors (sotorasib or adagrasib...

Enrolling
KRAS G12C Lung Cancer
Non-Small Cell Lung Cancer
Drug: Sotorasib
Drug: Divarasib

The main aim of this study is to find out how well elritercept works in lowering the need for RBC transfusions. Other aims are to learn how well elri...

Enrolling
Myelodysplastic Syndromes
Drug: Placebo
Drug: Elritercept

This trial will evaluate the efficacy and safety of various therapies in participants with Stage IB, IIA, IIB, IIIA, or selected IIIB resectable and...

Enrolling
Non-small Cell Lung Cancer
Procedure: Resection
Drug: Pralsetinib

This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture...

Enrolling
Open Midline Laparotomy
Device: Phasix™ Mesh

This prospective, multi-center, randomized, controlled clinical trial is being conducted to evaluate the safety and efficacy of the pdSTIM System to...

Enrolling
Ventilator Induced Diaphragm Dysfunction
Device: pdSTIM System Therapy

This study will randomize patients recently discharged from the hospital with a confirmed diagnosis of type 1 acute myocardial infarction (Thygesen e...

Invitation-only
Acute Myocardial Infarction
Combination Product: Placebo
Combination Product: Selatogrel

The purpose of this phase 2/3 study is to confirm the recommended doses and to evaluate the safety and pharmacodynamics of Calaspargase pegol for the...

Active, not recruiting
Acute Lymphoblastic Leukemia
Drug: Calaspargase pegol (S95015)

The goal of this clinical study is to compare the study drug, sacituzumab govitecan-hziy (SG), versus docetaxel in participants with advanced or meta...

Active, not recruiting
Non-Small Cell Lung Cancer
Biological: Sacituzumab Govitecan-hziy (SG)
Drug: Docetaxel

This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of...

Enrolling
Lymphoid Malignancies
Drug: AVM0703

Trial sponsors

M
A
A
A
C
D
Forma Therapeutics logo
Genentech logo
Gilead Sciences logo
HiberCell logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems